{"id":27434,"date":"2026-09-24T15:20:30","date_gmt":"2026-09-24T13:20:30","guid":{"rendered":"https:\/\/makingpharmaindustry.it\/?p=27434"},"modified":"2026-09-24T15:48:20","modified_gmt":"2026-09-24T13:48:20","slug":"makingpharmaindustry-issue-3_2026-cphi-special","status":"publish","type":"post","link":"https:\/\/makingpharmaindustry.it\/en\/makingpharmaindustry-en\/makingpharmaindustry-issue-3_2026-cphi-special\/","title":{"rendered":"MakingPharmaIndustry | Issue 3_2025 | CPHI Special"},"content":{"rendered":"
On the occasion of CPHI Milan 2026<\/strong>, MakingPharmaIndustry returns with a special issue of its tabloid dedicated to the transformations reshaping the pharmaceutical industry.<\/div>\n
\n
\n
\n
\n
\n
\n
\n
\n

The common thread is the transition from innovation to industrial capability: developing a new therapy is only one part of the journey. Robust processes, scalable technologies, expertise, manufacturing capacity and quality systems are all needed to support increasingly complex products.<\/p>\n

A major section of the magazine is dedicated to Advanced Therapy Medicinal Products<\/strong>, viewed from a manufacturing perspective. Starting materials and biological variability become part of the control strategy; closed systems, automation and single-use technologies are changing the way facilities are designed; scale-out is replacing traditional scale-up, while the manufacturing network itself becomes an integral part of the product.<\/p>\n

Analytics is also taking on a different role. For advanced therapies, identity, purity and sterility are not enough: the product must also retain the biological function for which it was developed. This is why the issue focuses on potency<\/strong>, one of the most complex challenges in ATMP development and manufacturing.<\/p>\n

The perspective then broadens to Europe and its ability to turn scientific excellence into industrial growth. Europe\u2019s biotech challenge increasingly emerges after discovery: financing development, scaling up, building biomanufacturing capacity, and retaining expertise and value within the region.<\/p>\n

Alongside the editorial features, the issue explores technologies and industry experience across engineering, equipment, qualification, packaging, analytical characterization and performance throughout the entire lifecycle<\/strong>, with contributions and perspectives from companies working every day in pharmaceutical manufacturing.<\/p>\n

24 pages to look at CPHI not only as a technology showcase, but as a privileged vantage point on how the pharmaceutical industry is changing.<\/strong><\/p>\n

Want to explore all the features?<\/p>\n

Visit us at CPHI Milan 2026<\/strong>, or browse the digital edition online.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n